New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
08:32 EDTTHC, UNHUnitedHealthcare, Tenet renew network relationship
UnitedHealthcare, a UnitedHealth Group company (UNH), and Tenet Healthcare Corporation (THC) have completed a new, three-year agreement providing UnitedHealthcare’s Commercial and Medicare Advantage members with in-network access to Tenet’s 79 hospitals, 193 outpatient centers and more than 1,800 employed physicians throughout the country. The new agreement is effective August 1, 2014. “This agreement provides consumers uninterrupted access to quality care in their local communities,” said Dan Rosenthal, president of UnitedHealthcare Networks. “We are pleased to renew this national contract with Tenet which gives our members access to providers focused on driving care improvements and offers competitive reimbursement rates, a portion of which, importantly, rewards Tenet for achieving certain quality measures.”
News For UNH;THC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 30, 2015
12:22 EDTUNHOn The Fly: Midday Wrap
Subscribe for More Information
10:59 EDTUNHUnitedHealth in 'ring' with largest competitors after deal, say Piper Jaffray
Subscribe for More Information
09:29 EDTUNHCatamaran buyout a 'significant positive' for holders, says Leerink
Leerink views the buyout by UnitedHealth (UNH) as a "significant positive" for the shareholders of Catamaran (CTRX). The firm does not expect additional bidders to emerge. It also believes Catamaran will retain Cigna (CI) and HealthSpring as a client given the long-term nature of the contract and Catamaran's expertise in Medicare.
09:27 EDTUNHOn The Fly: Pre-market Movers
Subscribe for More Information
07:41 EDTUNHUnitedHealth shares up 3.8% in pre-market trading following Catamaran deal
06:34 EDTUNHCatamaran Corporation options active into UnitedHealth's OptumRX acquiring
Subscribe for More Information
06:05 EDTUNHCatamaran CEO says board considered 'variety of strategic options'
Mark Thierer, chairman and CEO of Catamaran, said, “Our Board of Directors carefully considered a variety of strategic options and unanimously concluded that this combination is clearly in the best interests of our shareholders. The creation of a differentiated, channel-agnostic delivery model will provide payers and individuals a broader portfolio of services and a deeper product offering while aggressively focusing on managing costs. Together, we believe we will have the talent, scale, technology resources and innovative spirit to build the most modern, effective and consumer-focused PBM in the history of the industry.”
06:04 EDTUNHUnitedHealth's OptumRX to acquire Catamaran for $61.50 per share in cash
Subscribe for More Information
06:03 EDTUNHUnitedHealth's OptumRX to acquire Catamaran for $61.50 per share in cash
Subscribe for More Information
06:02 EDTUNHUnitedHealth to acquire Catamaran for $61.50 per share
March 25, 2015
10:00 EDTUNHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:38 EDTUNHPrice targets raised for Managed Care Organizations at UBS
UBS raised its price targets on the Managed Care Organizations in their coverage universe. The firm cites increased volumes, a lack of new legislation, the potential for industry consolidation, and limited exposure to international markets that face a weak macro economic backdrop. UBS raised its price target on Aetna (AET) to $128 from $120, Anthem (ANTM) to $175 from $163, Cigna (CI) to $149 from $140 and United Health (UNH) to $135 from $131. UBS has a Buy rating on all four stocks.
07:05 EDTUNHUnitedHealth initiated with a Buy at Mizuho
Subscribe for More Information
March 23, 2015
16:20 EDTTHCOn The Fly: Closing Wrap
Stocks on Wall Street opened in relatively quiet fashion and remained that way throughout the session until a sharp selloff in the closing minutes. For most of the day the averages moved in a narrow range, as the Dow broke its streak of consecutive days with triple digit moves. Like stocks, the oil markets had a quiet session that stood out amid the recent volatility in crude prices. A late day drop prevented the major stock indexes from adding to the big gains they'd notched on Friday. ECONOMIC EVENTS: In the U.S., the Chicago Fed's national activity index fell to -0.11 in February, below expectations for a reading of 0.10. Existing home sales rose 1.2% to a 4.88M rate in February, which was below the consensus forecast for them to grow 2% to a 4.92M unit rate. COMPANY NEWS: Shares of Kansas City Southern (KSU) declined $9.21, or 7.96%, to $106.48 after the railroad operator lowered its fiscal year revenue guidance to reflect slower year-to-date carload growth primarily from the energy sector, along with a continued deterioration in the value of the Mexican peso against the U.S. dollar and lower fuel surcharge revenues driven by lower WTI prices. The revenue warning appeared to weigh on others in the rail industry as well, with Union Pacific (UNP) falling $4.67, or 3.98%, to $112.78, Norfolk Southern (NSC) dropping $3.87, or 3.5%, to $106.56 and Canadian National (CNI) sliding $1.13, or 1.65%, to $67.24. MAJOR MOVERS: Among the notable gainers was ImmunoGen (IMGN), which gained $1.25, or 16.8%, to $8.69 after Takeda (TKPYY) licensed rights to use the company's antibody drug conjugate technology. Also higher was Tenet Healthcare (THC), which rose $2.45, or 4.94%, to $52.07 after agreeing to combine its short-stay surgery and imaging center assets into a new joint venture with United Surgical Partners International. Tenet will initially own 50.1% of the joint venture and will consolidate its financial results and will have a path to full ownership of USPI over the next five years through a put/call structure, the company noted. Among the noteworthy losers was MEI Pharma (MEIP), which plunged $4.37, or 69.37%, to $1.93 and was downgraded by at least four Wall Street research firms after the combination of Pracinostat and azacitidine showed no difference in the rate of complete remission, the primary endpoint of a Phase II study, compared to azacitidine alone. Also lower were shares of Vertex (VRTX), which fell $5.21, or 3.98%, to $125.79 after reporting data from a study evaluating VX-661 in combination with ivacaftor in cystic fibrosis that JPMorgan said was generally below expectations. INDEXES: The Dow fell 11.61, or 0.06%, to 18,116.04, the Nasdaq lost 15.44, or 0.31%, to 5,010.97, and the S&P 500 dropped 3.68, or 0.17%, to 2,104.42.
16:02 EDTTHCTenet announces partnership with Baylor Scott & White Health
Subscribe for More Information
10:05 EDTTHCTenet added to short-term buy list at Deutsche Bank
08:07 EDTTHCBofA/Merrill healthcare high yield analyst has analyst/industry conference call
Healthcare High Yield Analyst Bland provides an update on the current state of the bond markets and the ability of healthcare providers to utilize debt financing on an Analyst/Industry conference call to be held on March 24 at 10 am.
06:04 EDTTHCTenet, United Surgical Partners and Welsh Carson announce new joint venture
Subscribe for More Information
March 22, 2015
20:45 EDTTHCTenet getting close to deal for United Surgical Partners, WSJ says
Subscribe for More Information
March 20, 2015
08:18 EDTUNH, THCLeerink healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gupte discusses Sustainable Growth Rate (SGR) and the proposed pay-fors and implications For Healthcare Services on an Analyst/Industry conference call to be held on March 20 at 11 am.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use